Protagenic Therapeutics, Inc. ew
Protagenic Therapeutics, Inc. ew (ATRND) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 2 transactions totaling $75.3K, demonstrating a bullish sentiment with $75.3K in net insider flow. The most recent transaction on Aug 8, 2016 involved a transaction of 150,000 shares valued at $187.5K.
ATRND Recent Transactions
2 transactionsDate | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 8, 2016 | Barrage Khalil | Executive | Award | 150,000 | $1.25 | $187.5K | |
| Jun 17, 2016 | H. Armen Garo | Executive | Purchase | 60,211 | $1.25 | $75.3K |
ATRND Insider Activity Summary
Who Is Buying ATRND Stock?
No significant insider buying has been recorded for ATRND in the recent period.
Who Is Selling ATRND Stock?
No significant insider selling has been recorded for ATRND in the recent period.
Is Protagenic Therapeutics, Inc. ew Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ATRND is bullish with an Insider Alignment Score of 100/100 and a net flow of $75.3K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ATRND Frequently Asked Questions
Understanding ATRND Insider Activity
Insider trading at Protagenic Therapeutics, Inc. ew (ATRND) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading ATRND stock, having executed 2 transactions in the past 90 days. The most active insider is Khalil Barrage (Executive), who has made 1 transactions totaling $187.5K.
Related Tools
Track Protagenic Therapeutics, Inc. ew Insider Activity
Get notified when executives and directors at ATRND file new Form 4 transactions